Skin capillary density in subjects with impaired glucose tolerance and patients with Type 2 diabetes

被引:1
|
作者
Jaap, AJ [1 ]
Shore, AC [1 ]
Stockman, AJ [1 ]
Tooke, JE [1 ]
机构
[1] UNIV EXETER,POSTGRAD MED SCH,DEPT DIABET & VASC MED,EXETER EX4 4QJ,DEVON,ENGLAND
关键词
Type 2 diabetes mellitus; impaired glucose tolerance; microcirculation; capillary density; impaired development;
D O I
10.1002/(SICI)1096-9136(199602)13:2<160::AID-DIA36>3.0.CO;2-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In view of recent interest in the role of impaired early development and the pathogenesis of cardiovascular disease and carbohydrate intolerance in adults, this study examines whether reduced skin capillary density contributes to the limited microvascular hyperaemic responses observed in patients with Type 2 diabetes and subjects with impaired glucose tolerance (IGT). Fifteen patients with Type 2 diabetes, 15 subjects with IGT and 15 matched non-diabetic control subjects were studied. Capillary videomicroscopy was used to record images of the skin capillaries on the dorsum of the middle phalanx of the left middle Ginger before and after 10 min venous occlusion at 35 mmHg. There were no significant differences between the three groups in either basal capillary density (112 (71-144) caps mm(-2) Type 2 patients (median and range) vs 107 (76-140) caps mm(-2) IGT subjects vs 112(76-138) caps mm(-2) control subjects; p = 0.9, Kruskal Wallis), or following venous occlusion (122(87-157) caps mm(-2) vs 121 (90-143) caps mm(-2) vs 123 (81-147) caps mm(-1); p=0.9). In addition there were no differences in blood pressure, BMI or skin temperature. These results do not support the concept of impaired early development of the skin microcirculation in patients with Type 2 diabetes or IGT and suggest that mechanisms other than reduced capillary density are involved in limiting microvascular vasodilation.
引用
收藏
页码:160 / 164
页数:5
相关论文
共 50 条
  • [21] Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
    Tuomilehto, J
    Lindström, J
    Eriksson, JG
    Valle, TT
    Hamalainen, H
    Ilanne-Parikka, P
    Keinanen-Kiukaanniemi, S
    Laakso, M
    Louheranta, A
    Rastas, M
    Salminen, V
    Uusitupa, M
    Aunola, S
    Cepaitis, Z
    Moltchanov, V
    Hakumaki, M
    Mannelin, M
    Martikkala, V
    Sundvall, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (18): : 1343 - 1350
  • [22] Contribution of total and intact proinsulins to hyperinsulinism in subjects with obesity, impaired glucose tolerance or type 2 diabetes
    Blicklé, JF
    Sapin, R
    Andrès, E
    [J]. DIABETES & METABOLISM, 2000, 26 (04): : 274 - 280
  • [23] CVD RISK FACTORS IN SUBJECTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS AND IMPAIRED GLUCOSE TOLERANCE
    Garg, M. L.
    Gibson, L. Z.
    Godfrey, D. M.
    Green, J. M.
    Horan, B. P.
    Monger, K. L.
    Wischer, R. M.
    Blake, R. J.
    Macdonald-Wicks, L.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 97 : S17 - S17
  • [24] Genetic variation in uncoupling protein 2 gene is associated with type 2 diabetes in subjects with impaired glucose tolerance
    Salopuro, T
    Pulkkinen, L
    Lindström, J
    Tuomilehto, J
    Laakso, M
    Uusitupa, M
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S110 - S110
  • [25] Serum lipocalin-2 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes
    Che, Z.
    Tan, Y.
    Zhou, W.
    Zhou, P.
    Zhou, Z.
    Zhang, H.
    Xu, A.
    [J]. DIABETOLOGIA, 2008, 51 : S288 - S288
  • [26] Immunosuppressive markers of atherosclerosis in patients with impaired glucose tolerance and type 2 diabetes mellitus
    Chugunova, L. A.
    Galitsina, N. A.
    Sukhareva, O. Y.
    Knyazeva, A. P.
    Shestakova, M. V.
    [J]. DIABETES MELLITUS, 2005, 8 (02): : 54 - 58
  • [27] Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes
    Menge, Bjoern A.
    Schrader, Henning
    Ritter, Peter R.
    Ellrichmann, Mark
    Uhl, Waldemar
    Schmidt, Wolfgang E.
    Meier, Juris J.
    [J]. REGULATORY PEPTIDES, 2010, 160 (1-3) : 75 - 80
  • [28] Pioglitazone preserves pancreatic β-cells in patients with type 2 diabetes and impaired glucose tolerance
    Hamdy, O
    Soodini, G
    Martens, J
    Verheught, C
    Steppel, J
    Caballero, AE
    Bennani, T
    Horton, ES
    [J]. DIABETES, 2005, 54 : A146 - A146
  • [29] Markers of endothelium dysfunction in patients with Type 2 diabetes mellitus and impaired glucose tolerance
    Kowalska, I
    Straczkowski, M
    Stepien, A
    Kinalska, I
    [J]. DIABETOLOGIA, 2002, 45 : A401 - A401
  • [30] Changes of arterial hemodynamics in patients with type 2 diabetes mellitus or impaired glucose tolerance
    Milio, G
    Novo, G
    Ferrara, F
    Raimondi, F
    Novo, S
    [J]. INTERNATIONAL ANGIOLOGY, 2006, 25 (01) : 73 - 77